康美藥(yao)業(ye)(ye)股(gu)份有限(xian)公司(si)（簡稱(cheng)“康美藥(yao)業(ye)(ye)”）創建于1997年，2001年在(zai)滬交所(suo)掛牌上市，股(gu)票(piao)代碼600518，是一家(jia)以(yi)中藥(yao)飲片生產(chan)為核心，業(ye)(ye)務涵蓋中藥(yao)全產(chan)業(ye)(ye)鏈(lian)的現代化(hua)大型醫藥(yao)資源型企業(ye)(ye)、國家(jia)重點(dian)高(gao)新(xin)技術企業(ye)(ye)。

    康美藥(yao)業(ye)秉承“心懷蒼生，大(da)愛(ai)(ai)無疆”的(de)核心價值觀、“用愛(ai)(ai)感(gan)動世界，用心經營(ying)健康”的(de)經營(ying)理念，專注于(yu)中(zhong)(zhong)(zhong)醫(yi)藥(yao)事業(ye)，以促進行(xing)業(ye)發展(zhan)為(wei)(wei)己(ji)任，以提高人們健康水(shui)平為(wei)(wei)目標，響應(ying)廣(guang)東(dong)省“中(zhong)(zhong)(zhong)醫(yi)藥(yao)強(qiang)省建設”戰(zhan)略(lve)號召，積(ji)極打(da)造(zao)中(zhong)(zhong)(zhong)藥(yao)全產業(ye)鏈，不斷做強(qiang)做大(da)，已(yi)成為(wei)(wei)我國(guo)(guo)(guo)中(zhong)(zhong)(zhong)藥(yao)飲片(pian)龍(long)頭企(qi)業(ye)。公司(si)現(xian)有總(zong)資(zi)產194億(yi)(yi)元(yuan)，凈(jing)(jing)資(zi)產111億(yi)(yi)元(yuan)，員工5000多人。2012年(nian)實現(xian)銷售(shou)收入(ru)(ru)111.6億(yi)(yi)元(yuan)，同比增長(chang)83.62％；實現(xian)凈(jing)(jing)利潤14.41億(yi)(yi)元(yuan)，同比增長(chang)43.4％,股票(piao)市值達到380多億(yi)(yi)元(yuan)，在中(zhong)(zhong)(zhong)國(guo)(guo)(guo)資(zi)本市場(chang)大(da)醫(yi)藥(yao)行(xing)業(ye)排名第二。憑(ping)借在行(xing)業(ye)內的(de)影響力和資(zi)本市場(chang)上的(de)顯(xian)著地位，康美藥(yao)業(ye)作為(wei)(wei)新增樣本股進入(ru)(ru)了上證公司(si)治(zhi)理指數，先后獲評為(wei)(wei)中(zhong)(zhong)(zhong)國(guo)(guo)(guo)100家(jia)最(zui)具成長(chang)性上市公司(si)、中(zhong)(zhong)(zhong)國(guo)(guo)(guo)50家(jia)最(zui)受尊敬上市公司(si)、中(zhong)(zhong)(zhong)國(guo)(guo)(guo)民營(ying)企(qi)業(ye)制造(zao)業(ye)500強(qiang)、中(zhong)(zhong)(zhong)國(guo)(guo)(guo)制藥(yao)工業(ye)百強(qiang)。

    積(ji)極實施中(zhong)藥(yao)(yao)(yao)(yao)(yao)全(quan)(quan)產(chan)業(ye)(ye)(ye)(ye)鏈(lian)(lian)戰略。公司先后(hou)在全(quan)(quan)國(guo)各地(di)(di)(di)投資(zi)超過50億元建(jian)立(li)17個(ge)涵蓋(gai)藥(yao)(yao)(yao)(yao)(yao)材(cai)(cai)種(zhong)植(zhi)、中(zhong)藥(yao)(yao)(yao)(yao)(yao)材(cai)(cai)交(jiao)易市場、現代(dai)物流(liu)中(zhong)心和產(chan)業(ye)(ye)(ye)(ye)基地(di)(di)(di)等(deng)(deng)業(ye)(ye)(ye)(ye)務的(de)(de)企業(ye)(ye)(ye)(ye)，采取(qu)“公司+農(nong)戶”的(de)(de)合(he)作(zuo)方式與道地(di)(di)(di)藥(yao)(yao)(yao)(yao)(yao)材(cai)(cai)產(chan)地(di)(di)(di)農(nong)民合(he)作(zuo)，在云南、四川(chuan)、吉(ji)林(lin)、甘肅(su)等(deng)(deng)地(di)(di)(di)建(jian)立(li)超過5萬畝規范化(hua)種(zhong)植(zhi)基地(di)(di)(di)。在廣東(dong)、北京、上海、四川(chuan)、吉(ji)林(lin)、安(an)徽、甘肅(su)等(deng)(deng)地(di)(di)(di)建(jian)立(li)了(le)9個(ge)中(zhong)藥(yao)(yao)(yao)(yao)(yao)飲(yin)片生(sheng)(sheng)產(chan)基地(di)(di)(di)，覆蓋(gai)全(quan)(quan)國(guo)的(de)(de)生(sheng)(sheng)產(chan)布局已(yi)經基本完(wan)成。并購安(an)徽亳州(zhou)等(deng)(deng)中(zhong)藥(yao)(yao)(yao)(yao)(yao)材(cai)(cai)專(zhuan)(zhuan)業(ye)(ye)(ye)(ye)市場，接管(guan)康(kang)美（普寧）中(zhong)藥(yao)(yao)(yao)(yao)(yao)材(cai)(cai)專(zhuan)(zhuan)業(ye)(ye)(ye)(ye)市場，新建(jian)全(quan)(quan)國(guo)最大(da)的(de)(de)康(kang)美（亳州(zhou)）華佗國(guo)際(ji)中(zhong)藥(yao)(yao)(yao)(yao)(yao)城，管(guan)理全(quan)(quan)國(guo)75%以上的(de)(de)藥(yao)(yao)(yao)(yao)(yao)材(cai)(cai)交(jiao)易專(zhuan)(zhuan)業(ye)(ye)(ye)(ye)市場。在廣東(dong)普寧市區投資(zi)6億元建(jian)設全(quan)(quan)市第一家民營三甲標準綜合(he)醫院，床(chuang)位(wei)數超過950張，大(da)大(da)緩解當地(di)(di)(di)醫療資(zi)源配置不足的(de)(de)局面。目前，上至藥(yao)(yao)(yao)(yao)(yao)材(cai)(cai)種(zhong)植(zhi)、藥(yao)(yao)(yao)(yao)(yao)材(cai)(cai)交(jiao)易，下至生(sheng)(sheng)產(chan)開發、終端銷售，康(kang)美藥(yao)(yao)(yao)(yao)(yao)業(ye)(ye)(ye)(ye)已(yi)基本貫穿中(zhong)藥(yao)(yao)(yao)(yao)(yao)產(chan)業(ye)(ye)(ye)(ye)鏈(lian)(lian)的(de)(de)上、中(zhong)、下游(you)產(chan)業(ye)(ye)(ye)(ye)，業(ye)(ye)(ye)(ye)務已(yi)滲透到中(zhong)藥(yao)(yao)(yao)(yao)(yao)產(chan)業(ye)(ye)(ye)(ye)鏈(lian)(lian)的(de)(de)各個(ge)關鍵(jian)環(huan)節(jie)，為最大(da)程度(du)整合(he)全(quan)(quan)產(chan)業(ye)(ye)(ye)(ye)鏈(lian)(lian)資(zi)源創造了(le)優(you)勢條件。

    構(gou)建完善營(ying)銷(xiao)網(wang)絡(luo)，創新(xin)商業模(mo)式(shi)。公(gong)司(si)在北(bei)京(jing)、上海、廣州(zhou)、深圳、成(cheng)(cheng)都(dou)等(deng)全(quan)國20多個城市(shi)設(she)立(li)了(le)分（子）公(gong)司(si)、辦事處，在華(hua)北(bei)、華(hua)東、華(hua)南、西(xi)南、東北(bei)等(deng)區域(yu)形成(cheng)(cheng)了(le)較為完善的(de)市(shi)場(chang)營(ying)銷(xiao)網(wang)絡(luo)，構(gou)建了(le)集(ji)(ji)醫(yi)院銷(xiao)售、OTC、西(xi)藥(yao)(yao)(yao)(yao)批發(fa)與配送、零售、連鎖藥(yao)(yao)(yao)(yao)店、電子商務(wu)等(deng)多種方式(shi)于一體(ti)的(de)立(li)體(ti)銷(xiao)售體(ti)系。公(gong)司(si)與中(zhong)(zhong)國人(ren)保(bao)集(ji)(ji)團共同(tong)成(cheng)(cheng)立(li)健(jian)康(kang)管理公(gong)司(si)，攜(xie)手(shou)開展(zhan)健(jian)康(kang)管理服(fu)務(wu)和(he)健(jian)康(kang)產(chan)品銷(xiao)售，打造(zao)健(jian)康(kang)產(chan)品的(de)安利模(mo)式(shi)。大力推(tui)進電子商務(wu)建設(she)，拓展(zhan)新(xin)的(de)銷(xiao)售渠道，建成(cheng)(cheng)了(le)康(kang)美(mei)醫(yi)藥(yao)(yao)(yao)(yao)網(wang)（）、康(kang)美(mei)中(zhong)(zhong)藥(yao)(yao)(yao)(yao)網(wang)（），以及全(quan)國唯一的(de)“實體(ti)市(shi)場(chang)與虛(xu)擬市(shi)場(chang)相結合”的(de)集(ji)(ji)中(zhong)(zhong)藥(yao)(yao)(yao)(yao)材(cai)信息服(fu)務(wu)、中(zhong)(zhong)藥(yao)(yao)(yao)(yao)材(cai)電子交易與結算服(fu)務(wu)為一體(ti)的(de)中(zhong)(zhong)藥(yao)(yao)(yao)(yao)材(cai)大宗交易平臺()。

    大(da)(da)力(li)推(tui)進(jin)協同創新(xin)，不斷提高自主(zhu)創新(xin)能(neng)力(li)。公司(si)現擁(yong)有(you)國(guo)(guo)(guo)(guo)(guo)(guo)內(nei)(nei)唯一的(de)(de)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)飲(yin)片(pian)(pian)(pian)國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)地方聯合(he)工(gong)程(cheng)研(yan)究(jiu)(jiu)(jiu)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)心、中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)飲(yin)片(pian)(pian)(pian)標準(zhun)重點研(yan)究(jiu)(jiu)(jiu)室，以及(ji)擁(yong)有(you)廣(guang)東省(sheng)(sheng)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)標準(zhun)化技(ji)術(shu)委員(yuan)會、廣(guang)東省(sheng)(sheng)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)飲(yin)片(pian)(pian)(pian)工(gong)程(cheng)技(ji)術(shu)研(yan)究(jiu)(jiu)(jiu)開(kai)發中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)心、廣(guang)東省(sheng)(sheng)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)飲(yin)片(pian)(pian)(pian)企(qi)(qi)業(ye)重點實驗室、廣(guang)東中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)產(chan)業(ye)技(ji)術(shu)創新(xin)聯盟等(deng)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)產(chan)業(ye)公共服務和(he)技(ji)術(shu)創新(xin)支撐平臺，建立了(le)廣(guang)東省(sheng)(sheng)企(qi)(qi)業(ye)技(ji)術(shu)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)心、企(qi)(qi)業(ye)博士后(hou)科研(yan)工(gong)作站，獨家(jia)(jia)承(cheng)擔(dan)(dan)編制(zhi)(zhi)(zhi)和(he)運營我國(guo)(guo)(guo)(guo)(guo)(guo)唯一一個全國(guo)(guo)(guo)(guo)(guo)(guo)性的(de)(de)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)材價格指數——康美(mei)?中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)(guo)(guo)(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)材價格指數（），開(kai)創了(le)民(min)營企(qi)(qi)業(ye)承(cheng)擔(dan)(dan)國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)價格信(xin)息化建設(she)(she)先河(he)。與中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)(guo)(guo)(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)醫研(yan)究(jiu)(jiu)(jiu)院(yuan)、廣(guang)州(zhou)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)醫藥(yao)(yao)大(da)(da)學等(deng)國(guo)(guo)(guo)(guo)(guo)(guo)內(nei)(nei)科研(yan)機構緊密合(he)作，組(zu)建了(le)陳可冀、王永炎等(deng)7位中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)科院(yuan)、工(gong)程(cheng)院(yuan)院(yuan)士組(zu)成(cheng)的(de)(de)專家(jia)(jia)委員(yuan)會。成(cheng)立康美(mei)藥(yao)(yao)物研(yan)究(jiu)(jiu)(jiu)院(yuan)，承(cheng)擔(dan)(dan)了(le)多個國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)科技(ji)支撐計劃項(xiang)目，率先提出并實施中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)飲(yin)片(pian)(pian)(pian)小包裝和(he)色標管(guan)(guan)理,成(cheng)為(wei)國(guo)(guo)(guo)(guo)(guo)(guo)內(nei)(nei)唯一參(can)與國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)標準(zhun)制(zhi)(zhi)(zhi)訂的(de)(de)企(qi)(qi)業(ye)，參(can)與多項(xiang)國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)和(he)省(sheng)(sheng)級飲(yin)片(pian)(pian)(pian)炮制(zhi)(zhi)(zhi)和(he)質(zhi)量標準(zhun)制(zhi)(zhi)(zhi)訂，規范(fan)并提高了(le)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)飲(yin)片(pian)(pian)(pian)質(zhi)量及(ji)行業(ye)水平。擁(yong)有(you)治(zhi)療(liao)心腦血管(guan)(guan)、呼吸道感染等(deng)疾病中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)成(cheng)藥(yao)(yao)產(chan)品41個，4個國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)級新(xin)藥(yao)(yao)在內(nei)(nei)的(de)(de)20多種化學藥(yao)(yao)品及(ji)原料藥(yao)(yao)。中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)醫養生(sheng)專家(jia)(jia)精心研(yan)制(zhi)(zhi)(zhi)而成(cheng)的(de)(de)康美(mei)菊皇茶已成(cheng)為(wei)國(guo)(guo)(guo)(guo)(guo)(guo)內(nei)(nei)銷(xiao)量最(zui)大(da)(da)的(de)(de)保(bao)健(jian)袋裝茶，擁(yong)有(you)“康美(mei)”、“新(xin)開(kai)河(he)”兩個中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)(guo)(guo)(guo)馳名商標，發明專利(li)27件(jian)、外(wai)觀設(she)(she)計專利(li)35件(jian)、軟(ruan)件(jian)著作權11件(jian)。

    打造百年(nian)康(kang)美，推進企業(ye)文化(hua)建設。公(gong)司投入巨資先后打造了(le)《康(kang)美之(zhi)戀(lian)》、《國參傳奇(qi)》、《菊皇茶語》等大型音樂(le)電視，開創了(le)中藥(yao)企業(ye)文化(hua)營銷先河，創建了(le)一個極(ji)具代表(biao)性的(de)中藥(yao)民族企業(ye)品(pin)牌，“康(kang)美”品(pin)牌走(zou)進千家(jia)萬(wan)戶。積極(ji)承擔社會責任，熱(re)心公(gong)益慈善(shan)事業(ye)，多年(nian)來，公(gong)司捐(juan)款捐(juan)物2億多元(yuan)，受到社會的(de)廣泛認(ren)可。

    康美藥業(ye)(ye)將(jiang)繼(ji)續根植于中(zhong)醫藥產業(ye)(ye)，進一(yi)步打(da)造(zao)中(zhong)藥全產業(ye)(ye)鏈，增強各個業(ye)(ye)務環節(jie)的(de)競爭力，創(chuang)新集團管(guan)理模式，成(cheng)為一(yi)個具有核(he)心競爭力的(de)世(shi)界(jie)級中(zhong)醫藥企業(ye)(ye)。

     我們熱誠期盼與醫(yi)藥界廣大朋友攜手合作，共同推動(dong)我國醫(yi)藥事業(ye)健康(kang)發展(zhan)。